Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 448

1.

The cost-effectiveness of using hepatitis A/B combined vaccine versus hepatitis B vaccine alone for high-risk heterosexuals.

Rein DB, Weinbaum CM.

Vaccine. 2008 Oct 3;26(42):5331-3. doi: 10.1016/j.vaccine.2008.07.089. Epub 2008 Aug 14.

PMID:
18706957
2.

The cost effectiveness of hepatitis immunization for US college students.

Jacobs RJ, Saab S, Meyerhoff AS.

J Am Coll Health. 2003 May;51(6):227-36.

PMID:
14510025
3.

Cost effectiveness of hepatitis A/B versus hepatitis B vaccination for US prison inmates.

Jacobs RJ, Rosenthal P, Meyerhoff AS.

Vaccine. 2004 Mar 12;22(9-10):1241-8.

PMID:
15003653
4.

Regional variation in the cost effectiveness of childhood hepatitis A immunization.

Jacobs RJ, Greenberg DP, Koff RS, Saab S, Meyerhoff AS.

Pediatr Infect Dis J. 2003 Oct;22(10):904-14.

PMID:
14551492
5.

Cost effectiveness of hepatitis B vaccination strategies in Ireland: an economic evaluation.

Tilson L, Thornton L, O'Flanagan D, Johnson H, Barry M.

Eur J Public Health. 2008 Jun;18(3):275-82. Epub 2007 Dec 26. Erratum in: Eur J Public Health. 2008 Dec;18(6):693.

PMID:
18160389
6.

Efficiency of the incorporation of the hepatitis A vaccine as a combined A+B vaccine to the hepatitis B vaccination programme of preadolescents in schools.

Navas E, Salleras L, Gisbert R, Dominguez A, Bruguera M, Rodríguez G, Galí N, Prat A.

Vaccine. 2005 Mar 18;23(17-18):2185-9.

PMID:
15755592
9.

Cost-effectiveness analyses of hepatitis A vaccine: a systematic review to explore the effect of methodological quality on the economic attractiveness of vaccination strategies.

Anonychuk AM, Tricco AC, Bauch CT, Pham B, Gilca V, Duval B, John-Baptiste A, Woo G, Krahn M.

Pharmacoeconomics. 2008;26(1):17-32. Review.

PMID:
18088156
10.

Cost-effectiveness of hepatitis A vaccination for individuals with chronic hepatitis C.

Chapko MK, Yee HS, Monto A, Dominitz JA.

Vaccine. 2010 Feb 17;28(7):1726-31. doi: 10.1016/j.vaccine.2009.12.019. Epub 2009 Dec 29.

PMID:
20044051
11.

The cost-effectiveness of introducing hepatitis B vaccine into infant immunization services in Mozambique.

Griffiths UK, Hutton G, Das Dores Pascoal E.

Health Policy Plan. 2005 Jan;20(1):50-9.

PMID:
15689430
12.

Cost-effectiveness of hepatitis A and B vaccination programme in Germany.

Szucs T.

Vaccine. 2000 Feb 18;18 Suppl 1:S86-9.

PMID:
10683559
13.
14.

A reappraisal of hepatitis B virus vaccination strategies using cost-effectiveness analysis.

Bloom BS, Hillman AL, Fendrick AM, Schwartz JS.

Ann Intern Med. 1993 Feb 15;118(4):298-306.

PMID:
8420448
15.

Hepatitis B vaccination: the cost effectiveness of alternative strategies in England and Wales.

Mangtani P, Hall AJ, Normand CE.

J Epidemiol Community Health. 1995 Jun;49(3):238-44.

16.

The A's and B's of vaccine-preventable hepatitis: improving prevention in high-risk adults.

Oldfield EC 3rd, Keeffe EB.

Rev Gastroenterol Disord. 2007 Winter;7(1):1-21. Review.

PMID:
17392626
17.

Cost effectiveness of hepatitis B vaccination at HIV counseling and testing sites.

Kim SY, Billah K, Lieu TA, Weinstein MC.

Am J Prev Med. 2006 Jun;30(6):498-506.

PMID:
16704944
19.

Prospects for vaccination against hepatitis A and B in Catalonia (Spain).

Salleras L, Bruguera M, Buti M, Domíngez A.

Vaccine. 2000 Feb 18;18 Suppl 1:S80-2.

PMID:
10683557
20.

Cost-effectiveness of childhood hepatitis A vaccination in Argentina: a second dose is warranted.

Ellis A, Rüttimann RW, Jacobs RJ, Meyerhoff AS, Innis BL.

Rev Panam Salud Publica. 2007 Jun;21(6):345-56.

PMID:
17761046

Supplemental Content

Support Center